Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Short term Debt (2022 - 2023)

Historic Short term Debt for TriSalus Life Sciences (TLSI) over the last 2 years, with Q2 2023 value amounting to $10.0 million.

  • TriSalus Life Sciences' Short term Debt changed N/A to $10.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $10.0 million, marking a year-over-year change of. This contributed to the annual value of $15.8 million for FY2022, which is N/A changed from last year.
  • As of Q2 2023, TriSalus Life Sciences' Short term Debt stood at $10.0 million.
  • Over the past 5 years, TriSalus Life Sciences' Short term Debt peaked at $15.8 million during Q4 2022, and registered a low of $4.7 million during Q1 2023.